Regeneron Pharmaceuticals Inc
XBER:RGO

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
XBER:RGO
Watchlist
Price: 128.94 EUR 0.71% Market Closed
Market Cap: 13.9B EUR

Intrinsic Value

RGO price has not been updated for more than 10 years. This may indicate that the stock has been delisted.

The intrinsic value of one RGO stock under the Base Case scenario is 156.82 EUR. Compared to the current market price of 128.94 EUR, Regeneron Pharmaceuticals Inc is Undervalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RGO Intrinsic Value
156.82 EUR
Undervaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Regeneron Pharmaceuticals Inc

What is Valuation History?
Compare RGO to

Fundamental Analysis

Regeneron Pharmaceuticals Inc
XBER:RGO
US
Biotechnology
Market Cap
14B EUR
IPO
Apr 2, 1991
US
Biotechnology
Market Cap
14B EUR
IPO
Apr 2, 1991
Price
false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Regeneron’s overreliance on Eylea for a significant portion of its revenue poses a major risk, especially as new anti-VEGF therapies and biosimilars could challenge its market share in retinal diseases and pressure pricing.

Bull Theses

Despite Eylea’s looming patent expiry, potential label expansions for Dupixent and newer pipeline candidates like pozelimab could diversify revenue sources and provide steady earnings growth.

Show More Less
How do you feel about REGN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Regeneron Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Regeneron Pharmaceuticals Inc

Current Assets 17.6B
Cash & Short-Term Investments 8.3B
Receivables 5.6B
Other Current Assets 3.7B
Non-Current Assets 20B
Long-Term Investments 9.3B
PP&E 4.7B
Intangibles 1.2B
Other Non-Current Assets 4.8B
Efficiency

Free Cash Flow Analysis
Regeneron Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Regeneron Pharmaceuticals Inc

Revenue
14.1B USD
Cost of Revenue
-1.9B USD
Gross Profit
12.2B USD
Operating Expenses
-8.1B USD
Operating Income
4.1B USD
Other Expenses
435.8m USD
Net Income
4.5B USD
Fundamental Scores

RGO Profitability Score
Profitability Due Diligence

Regeneron Pharmaceuticals Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional Gross Margin
Positive 3Y Average ROE
Strong 3Y Average Gross Margin
58/100
Profitability
Score

Regeneron Pharmaceuticals Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

RGO Solvency Score
Solvency Due Diligence

Regeneron Pharmaceuticals Inc's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
97/100
Solvency
Score

Regeneron Pharmaceuticals Inc's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RGO Price Targets Summary
Regeneron Pharmaceuticals Inc

Wall Street analysts forecast RGO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGO is 645.69 EUR with a low forecast of 438.09 EUR and a high forecast of 915.4 EUR.

Lowest
Price Target
438.09 EUR
240% Upside
Average
Price Target
645.69 EUR
401% Upside
Highest
Price Target
915.4 EUR
610% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for REGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

REGN Insider Trading
Buy and sell transactions by insiders

RGO News

Other Videos
What is the Intrinsic Value of one RGO stock?

The intrinsic value of one RGO stock under the Base Case scenario is 156.82 EUR.

Is RGO stock undervalued or overvalued?

Compared to the current market price of 128.94 EUR, Regeneron Pharmaceuticals Inc is Undervalued by 18%.

Back to Top